R&D

Research & Development Critical & Cutting-Edge At Abeona we are focused on treating rare diseases and serving patient communities through our pioneering work in gene therapy. Learn more about our products below. ABO-101 for MPS IIIB and ABO-102 for MPS IIIA (Sanfilippo syndrome) Abeona is developing next generation adeno-associated viral (AAV)-based gene therapies for MPS … Continue reading R&D